Veracyte Ownership | Who Owns Veracyte?


OverviewForecastRevenueFinancialsChartTranscripts

Veracyte Ownership Summary


Veracyte is owned by 4.62% institutional investors, 0.49% insiders, and 94.90% retail investors. Vanguard group is the largest institutional shareholder, holding 10.66% of VCYT shares. Vanguard Explorer Inv is the top mutual fund, with 3.40% of its assets in Veracyte shares.

VCYT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVeracyte4.62%0.49%94.90%
SectorHealthcare Stocks 279.18%10.62%-189.80%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group8.21M10.66%$325.18M
Blackrock7.79M10.42%$168.88M
Blackrock funding, inc. /de7.53M9.77%$298.00M
Artisan partners limited partnership6.60M8.57%$261.33M
Ark investment management4.20M5.46%$166.48M
Wellington management group llp4.08M5.30%$161.75M
Arrowmark colorado3.08M4.00%$121.97M
State street2.91M3.89%$63.03M
Dimensional fund advisors lp2.88M3.74%$114.16M
Nikko asset management americas2.49M3.24%$98.66M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Silverarc capital management503.28K4.36%$19.93M
Perkins capital management90.20K3.17%$3.57M
Next century growth investors577.68K1.71%$22.88M
Arrowmark colorado3.08M1.64%$121.97M
Oberweis asset management inc/748.72K1.40%$29.65M
Ark investment management4.20M1.39%$166.48M
Efg asset management (north america)206.23K1.11%$8.16M
Granite investment partners649.02K1.11%$25.70M
Nikko asset management americas2.49M1.07%$98.66M
Casdin capital276.31K0.67%$8.19M

Top Buyers

HolderShares% AssetsChange
Fmr2.08M0.00%2.02M
Artisan partners limited partnership6.60M0.39%1.58M
Marshall wace, llp956.58K0.05%846.49K
Blackrock7.79M0.00%581.69K
Point72 asset management523.16K0.05%523.16K

Top Sellers

HolderShares% AssetsChange
State street2.91M0.00%-1.42M
William blair investment management---811.79K
Champlain investment partners---800.36K
Ark investment management4.20M1.39%-716.79K
Fiera capital---625.54K

New Positions

HolderShares% AssetsChangeValue
Loomis sayles & co l p409.70K0.02%409.70K$16.22M
Norges bank225.60K0.00%225.60K$8.93M
Raymond james financial41.06K0.00%41.06K$1.63M
D.a. davidson23.35K0.01%23.35K$924.82K
Y-intercept (hong kong)21.36K0.06%21.36K$845.90K

Sold Out

HolderChange
Newedge advisors-2.00
Kohmann bosshard financial services-6.00
Opal wealth advisors-13.00
First command advisory services-20.00
Covestor-22.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20259-97.20%3,530,599-95.70%40.04%5-96.84%3-97.41%
Dec 31, 20243012.73%77,106,580-5.52%1000.89%145-9.94%10922.47%
Sep 30, 202429222.18%81,612,672-0.60%1050.88%16238.46%887.32%
Jun 30, 2024239-2.05%82,106,4620.48%1090.92%117-21.48%8224.24%
Mar 31, 2024244-3.17%81,711,2235.83%1090.98%14929.57%66-37.14%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Explorer Inv2.66M3.40%-37.11K
ARK Disruptive Innovation Full Composite2.48M3.18%-205.91K
Vanguard Total Stock Mkt Idx Inv2.48M3.17%41.22K
Vanguard US Total Market Shares ETF2.46M3.16%2.69K
iShares Russell 2000 ETF2.00M2.55%978.00
Vanguard Small Cap Index1.95M2.48%9.19K
ARK Innovation ETF1.90M2.42%-2.84K
Fidelity Select Medical Tech and Devcs1.89M2.41%446.33K
Nikko AM ARK Disruptive Innovation A USD1.46M1.87%-202.63K
Fidelity Select Health Care1.28M1.64%435.00K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 04, 2025Leite John Chief Commercial Officer-CLIASell$76.41K
Mar 07, 2025Leite John Chief Commercial Officer-CLIASell$74.48K
Mar 07, 2025Leite John Chief Commercial Officer-CLIASell$160.15K
Mar 04, 2025Febbo Phillip G. Chief Scientific & Med OfficerSell$121.21K
Mar 04, 2025Febbo Phillip G. Chief Scientific & Med OfficerSell$146.81K

Insider Transactions Trends


DateBuySell
2025 Q2-1
2025 Q1-12
2024 Q4-13
2024 Q3-21
2024 Q2-5

VCYT Ownership FAQ


Who Owns Veracyte?

Veracyte shareholders are primarily institutional investors at 4.62%, followed by 0.49% insiders and 94.89% retail investors. The average institutional ownership in Veracyte's industry, Biotech Stocks , is 63.96%, which Veracyte falls below.

Who owns the most shares of Veracyte?

Veracyte’s largest shareholders are Vanguard group (8.21M shares, 10.66%), Blackrock (7.79M shares, 10.42%), and Blackrock funding, inc. /de (7.53M shares, 9.77%). Together, they hold 30.86% of Veracyte’s total shares outstanding.

Does Blackrock own Veracyte?

Yes, BlackRock owns 10.42% of Veracyte, totaling 7.79M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 168.88M$. In the last quarter, BlackRock increased its holdings by 581.69K shares, a 8.07% change.

Who is Veracyte’s biggest shareholder by percentage of total assets invested?

Silverarc capital management is Veracyte’s biggest shareholder by percentage of total assets invested, with 4.36% of its assets in 503.28K Veracyte shares, valued at 19.93M$.

Who is the top mutual fund holder of Veracyte shares?

Vanguard Explorer Inv is the top mutual fund holder of Veracyte shares, with 3.40% of its total shares outstanding invested in 2.66M Veracyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools